The impact of finally publishing a negative study: New conclusions about endothelin antagonists

Journal of Cardiac Failure

Volumn 11, Issue 1, 2005, Pages 21-22

  Gottlieb, Stephen S ^a  

^a UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; DARUSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; LIVER ENZYME; PLACEBO;

ANEMIA; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; DRUG EFFECT; EDITORIAL; FLUID RETENTION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; PRIORITY JOURNAL; SIDE EFFECT;

EID: 13444252603     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2004.11.002     Document Type: Editorial

References (9)

1. G. Ertl, and J. Bauersachs Endothelin receptor antagonists in heart failure: current status and future directions Drugs 64 2004 1029 1040
2. L.E. Spieker, and T.F. Luscher Will endothelin receptor antagonists have a role in heart failure? Med Clin North Am 87 2003 459 474
3. M. Packer, J. McMurray, and B.M. Massie Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study J Card Fail 11 2005 12 20
4. S.A. Hall, C.G. Cigarroa, L. Marcoux, R.C. Risser, P.A. Grayburn, and E.J. Eichhorn Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade J Am Coll Cardiol 25 1995 1154 1161
5. H. Shimaoyama, H.N. Sabbah, and S. Borzak Short term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure Circulation 94 1996 779 784
6. A Receptor Blockade Trial (HEAT) Circulation 106 2002 2666 2672
7. Q.T. Nguyen, P. Cernacek, and M.G. Sirois Long-term effects of nonselective endothelin A and B receptor antagonism in postinfarction rat: importance of timing Circulation 104 2001 2075 2081
8. M. Clozel, C. Qiu, C.S. Qiu, P. Hess, and J.P. Clozel Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction J Am Coll Cardiol 39 2002 142 147
9. I. Anand, J. McMurray, and J.N. Cohn Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial Lancet 364 2004 347 354